<DOC>
	<DOCNO>NCT02043951</DOCNO>
	<brief_summary>The registry enroll patient claudication critical limb ischemia angiographically significant lesion ( ) arteries low extremity . Subjects treat Lutonix® Drug Coated Balloon Catheter approve indication accord current country-specific Instructions Use ( IFU ) follow clinically 1 year .</brief_summary>
	<brief_title>Use Safety LUTONIX® Drug Coated Balloon Catheter Arteries Lower Extremity</brief_title>
	<detailed_description>This post-market registry intend assess clinical use safety Lutonix® Drug Coated Balloon Catheter heterogeneous patient population real world clinical practice . Up 500 patient enrolled order allow identification assessment rare adverse event ( AEs ) well outcomes subpopulation define subject lesion characteristic . All subject follow 1 year . This registry perform marketed device within indication use . There additional treatment exam take place within registry .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>1 . ≥ 18 year age ; 2 . Rutherford Clinical Category ≤ 5 ; 3 . Patient Legally Authorized Representative willing provide inform consent comply require follow ; 4 . Stenotic obstructive vascular lesion artery ( ) low extremity ; 5 . Lesion ( ) treat available LUTONIX Drug Coated Balloon Catheter device size matrix per current countryspecific IFU . 1 . Patient currently participate active phase another investigational drug device study ; 2 . Inability take recommended medication state IFU noncontrollable allergy contrast .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>